HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 352383Erstellt: 24. Oktober 2026
Ethyl Acetate → (R)-(-)-2-oxo-3-tert-butoxycarbonylamino-5-phenyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine
https://huagongshe.com/de/reaction/352383
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Ethyl Acetate | HCID 8857 | — |
| Edukt | 1-Cyclooctene | HCID 13609 | — |
| Edukt | (R)-2-oxo-3-tert-butoxycarbonylamino-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine | HCID 12988641 | — |
| Katalysator | HCID 178418390 | HCID 178418390 | — |
| Lösungsmittel | Cyclohexanone | HCID 7967 | — |
| Produkt | (R)-(-)-2-oxo-3-tert-butoxycarbonylamino-5-phenyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine | HCID 12988647 | 50,2% |
Reaktionsschritte
To a solution of 5 g of (R)-(+)-2-oxo-3-tert-butoxycarbonylamino-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine in 25 ml of cyclohexanone were added 5.96 g of cyclooctene and 0.5 g of 10% palladium carbon. The mixture was stirred at the internal temperature of 145° C. for 2.5 hours. After the reaction mixture was cooled to room temperature, 20 ml of ethyl acetate was added. The mixture was filtered and the filtrate was concentrated under reduced pressure. The residue was crystallized by adding thereto diisopropyl ether and n-hexane and the resulting crystals were collected by filtration, whereby 3.2 g of the title compound was obtained.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US06747022B2 |
|---|
| Quelldatensatz | uspto-grants-2004_06 |
|---|
| ORD ID | ord-cd97a41839564bccb51d26a6e8f7ae1f |
|---|
| Quellennotiz | uspto-grants-2004_06 |
|---|